D
CRISPR Therapeutics AG CRSP
$43.56 -$1.97-4.33%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
Weiss Ratings CRSP - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Rating D
Reward Index Very Weak
Risk Index Weak
Risk Grade D
Reward Grade E
Rating Factors CRSP - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Dividend Index --
Growth Index Weak
Efficiency Index Very Weak
Solvency Index Excellent
Total Return Index Weak
Volatility Index Weak
Beta / Standard Deviation CRSP - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Beta 2.10
Price History CRSP - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
7-Day Total Return -0.23%
30-Day Total Return 0.23%
60-Day Total Return -12.68%
90-Day Total Return -8.11%
Year to Date Total Return 5.04%
1-Year Total Return -44.86%
2-Year Total Return -9.20%
3-Year Total Return -27.89%
5-Year Total Return -1.76%
52-Week High % Change -44.29%
52-Week Low % Change 24.67%
Price CRSP - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
52-Week High Price $81.73
52-Week Low Price $36.52
52-Week Low Price (Date) Jan 13, 2025
52-Week High Price (Date) Mar 08, 2024
Valuation CRSP - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Market Cap 3.91B
Enterprise Value 2.23B
Price/Earnings (TTM) --
Earnings Per Share (TTM) -4.37
Earnings Per Share Growth 121.12%
Price/Earnings To Growth --
Price/Sales (TTM) 104.28
Price/Book (Q) 2.02
Enterprise Value/Revenue (TTM) 59.63
Price $43.52
Enterprise Value/EBITDA (TTM) -4.97
Enterprise Value/EBIT -4.77
Market Cap Category Mid Cap
Dividends and Shares CRSP - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Shares Outstanding 85.46M
Dividend Yield --
Div. Per Share (Most Recent) --
Dividend Per Share (TTM) --
Payout Ratio (TTM) --
Dividend Per Share (Most Recent) --
Company Info CRSP - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Phone Number 41 41 561 32 77
Address --
Website www.crisprtx.com
Country Switzerland
Year Founded 2013
Profitability CRSP - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Operating Margin (TTM) -1,250.37%
Profit Margin -981.54%
Management Effectiveness CRSP - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Return on Assets -13.04%
Return on Equity --
Income Statement CRSP - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Revenue (TTM) 37.31M
Total Revenue (TTM) 37.31M
Revenue Per Share $0.44
Gross Profit (TTM) -393.59M
EBITDA (TTM) -447.31M
EBIT (TTM) -466.57M
Net Income (TTM) -366.25M
Net Income Avl. to Common (TTM) -366.25M
Total Revenue Growth (Q YOY) -82.26%
Earnings Growth (Q YOY) -141.76%
EPS Diluted (TTM) -4.37
EPS Diluted Growth (Q YOY) -139.88%
Balance Sheet CRSP - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Cash and Short-Term Inv. (Q) 1.90B
Cash Per Share (Q) $22.28
Total Current Assets (Q) 1.94B
Total Preferred Equity (Q) --
Total Equity (Q) 1.93B
Current Ratio (Q) 22.068
Book Value Per Share (Q) $22.53
Total Assets (Q) 2.24B
Total Current Liabilities (Q) 87.78M
Total Debt (Q) 223.69M
Total Liabilities (Q) 309.95M
Total Common Equity (Q) 1.93B
Cash Flow CRSP - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Cash from Investing (TTM) -280.48M
Cash from Financing (TTM) 331.98M
Net Change in Cash (TTM) -91.29M
Levered Free Cash Flow (TTM) 99.69M
Cash from Operations (TTM) -142.77M
Weiss Ratings